These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 27489433)

  • 1. Synchronous Occurrence of Primary Cutaneous Anaplastic Large Cell Lymphoma and Squamous Cell Carcinoma.
    Park JH; Lee JH; Lim Y; Lee YJ; Lee DY
    Ann Dermatol; 2016 Aug; 28(4):491-4. PubMed ID: 27489433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cutaneous CD30 positive lymphoproliferative disorders with coexistent epithelial neoplasms: Report of two cases.
    Newland KM; McCormack CJ; Prince HM; Lade S
    Australas J Dermatol; 2015 Nov; 56(4):e83-7. PubMed ID: 25330922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pseudocarcinomatous hyperplasia in anaplastic large cell lymphoma, a mimicker of poorly differentiated squamous cell carcinoma: report of a case and review of the literature.
    Price A; Miller JH; Junkins-Hopkins JM
    J Cutan Pathol; 2015 Nov; 42(11):863-9. PubMed ID: 26040921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary cutaneous CD30 anaplastic large cell lymphoma with keratoacanthoma-like pseudocarcinomatous hyperplasia and marked eosinophilia and neutrophilia.
    Lin JH; Lee JY
    J Cutan Pathol; 2004 Jul; 31(6):458-61. PubMed ID: 15186435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymphomatoid papulosis with pseudocarcinomatous hyperplasia in a 7-year-old girl: a case report.
    Xiong J; Ma Y; Chen H; Xu X; Sun J
    J Cutan Pathol; 2016 May; 43(5):430-3. PubMed ID: 26531106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MUM1 expression in cutaneous CD30+ lymphoproliferative disorders: a valuable tool for the distinction between lymphomatoid papulosis and primary cutaneous anaplastic large-cell lymphoma.
    Kempf W; Kutzner H; Cozzio A; Sander CA; Pfaltz MC; Müller B; Pfaltz M
    Br J Dermatol; 2008 Jun; 158(6):1280-7. PubMed ID: 18410414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pseudocarcinomatous change in lymphomatoid papulosis and primary cutaneous CD30+ lymphoma: a clinicopathologic and immunohistochemical study of 6 patients.
    Scarisbrick JJ; Calonje E; Orchard G; Child FJ; Russell-Jones R
    J Am Acad Dermatol; 2001 Feb; 44(2):239-47. PubMed ID: 11174381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genomic Analysis of Cutaneous CD30-Positive Lymphoproliferative Disorders.
    Abdulla FR; Zhang W; Wu X; Honda K; Qin H; Cho H; Querfeld C; Zain J; Rosen ST; Chan WC; Parekh V; Song JY
    JID Innov; 2022 Jan; 2(1):100068. PubMed ID: 34977845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary cutaneous CD30+ lymphoproliferative disorders with DUSP22 translocation.
    Montes-Moreno S
    Pathologie (Heidelb); 2023 Dec; 44(Suppl 3):136-139. PubMed ID: 38010388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intralymphatic cutaneous anaplastic large cell lymphoma/lymphomatoid papulosis: expanding the spectrum of CD30-positive lymphoproliferative disorders.
    Samols MA; Su A; Ra S; Cappel MA; Louissant A; Knudson RA; Ketterling RP; Said J; Binder S; Harris NL; Feldman AL; Kim J; Kim YH; Gratzinger D
    Am J Surg Pathol; 2014 Sep; 38(9):1203-11. PubMed ID: 24805854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contribution of longitudinal follow up and clinical pathological correlation in the diagnosis CD30-positive skin infiltrates.
    De Souza A; Carter JB; Harris NL; Ferry JA; Duncan LM
    J Cutan Pathol; 2015 Jul; 42(7):452-8. PubMed ID: 25931140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new era for cutaneous CD30-positive T-cell lymphoproliferative disorders.
    Kempf W
    Semin Diagn Pathol; 2017 Jan; 34(1):22-35. PubMed ID: 27993440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary cutaneous anaplastic large cell lymphoma.
    Brown RA; Fernandez-Pol S; Kim J
    J Cutan Pathol; 2017 Jun; 44(6):570-577. PubMed ID: 28342276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is there a special relationship between CD30-positive lymphoproliferative disorders and epidermal proliferation?
    Cespedes YP; Rockley PF; Flores F; Ruiz P; Kaiser MR; Elgart GW
    J Cutan Pathol; 2000 Jul; 27(6):271-5. PubMed ID: 10885402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD30-Positive Lymphoproliferative Disorders.
    Nikolaenko L; Zain J; Rosen ST; Querfeld C
    Cancer Treat Res; 2019; 176():249-268. PubMed ID: 30596222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cutaneous CD30-positive T-cell lymphoproliferative disorders-clinical and histopathologic features, differential diagnosis, and treatment.
    Kempf W; Kerl K; Mitteldorf C
    Semin Cutan Med Surg; 2018 Mar; 37(1):24-29. PubMed ID: 29719017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pseudocarcinomatous Hyperplasia Masquerading as a Well-Differentiated Squamous Cell Carcinoma Associated With Primary Cutaneous Anaplastic Large-Cell Lymphoma.
    LaTour D; Lee MP; Gardner JT; Dao H; Kerstetter J; Elsensohn A
    Am J Dermatopathol; 2022 Dec; 44(12):952-954. PubMed ID: 36197055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD30+ lymphoproliferative disorder: primary cutaneous anaplastic large cell lymphoma followed by lymphomatoid papulosis.
    Aoki M; Niimi Y; Takezaki S; Azuma A; Seike M; Kawana S
    Br J Dermatol; 2001 Jul; 145(1):123-6. PubMed ID: 11453920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD30-positive lymphoproliferative disorders arising after regional therapy for recurrent melanoma: a report of two cases and analysis of CD30 expression.
    Gill K; Ariyan C; Wang X; Brady MS; Pulitzer M
    J Surg Oncol; 2014 Sep; 110(3):258-64. PubMed ID: 24891295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fascin expression in CD30-positive cutaneous lymphoproliferative disorders.
    Kempf W; Levi E; Kamarashev J; Kutzner H; Pfeifer W; Petrogiannis-Haliotis T; Burg G; Kadin ME
    J Cutan Pathol; 2002 May; 29(5):295-300. PubMed ID: 12100631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.